Discuss This Drug

EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor

CHEBI:CHEBI_35544

Definition

A compound or agent that combines with cyclooxygenases (EC 1.14.99.1) and thereby prevents its substrate-enzyme combination with arachidonic acid and the formation of icosanoids, prostaglandins, and thromboxanes.

Alternative Names

  • (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate,hydrogen-donor:oxygen oxidoreductase inhibitor
  • (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate,hydrogen-donor:oxygen oxidoreductase inhibitors
  • (PG)H synthase inhibitor
  • (PG)H synthase inhibitors
  • COX inhibitor
  • cyclooxygenase (EC 1.14.99.1) inhibitor
  • cyclooxygenase (EC 1.14.99.1) inhibitors
  • cyclooxygenase inhibitor
  • cyclooxygenase inhibitors
  • EC 1.14.99.1 (cyclooxygenase) inhibitor
  • EC 1.14.99.1 (cyclooxygenase) inhibitors
  • EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitors
  • EC 1.14.99.1 inhibitor
  • EC 1.14.99.1 inhibitors
  • fatty acid cyclooxygenase inhibitor
  • fatty acid cyclooxygenase inhibitors
  • PG synthetase inhibitor
  • PG synthetase inhibitors
  • prostaglandin endoperoxide synthetase inhibitor
  • prostaglandin endoperoxide synthetase inhibitors
  • prostaglandin G/H synthase inhibitor
  • prostaglandin G/H synthase inhibitors
  • prostaglandin synthase inhibitor
  • prostaglandin synthase inhibitors
  • prostaglandin synthetase inhibitor
  • prostaglandin synthetase inhibitors

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:35544

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
oboInOwl#id
CHEBI:35544
core#notation
CHEBI:35544
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_9362
owl#someValuesFrom
t321197
owl#annotatedSource
t200815